Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2835744010 | Saxagliptin 5mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 2838060017 | Saxagliptin 5mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
| 3471275011 | Product containing saxagliptin 5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3488136011 | Product containing saxagliptin 5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3502272013 | Saxagliptin 5 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3570803010 | Product containing only saxagliptin 5 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3570804016 | Product containing only saxagliptin 5 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3682917016 | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3682918014 | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 59644101000001111 | Saxagliptin 5mg tablets | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Onglyza 5mg tablets (Ethigen Ltd) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (Pharmaram Ltd) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (CST Pharma Ltd) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (DE Pharmaceuticals) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Saxagliptin 5mg tablets 28 tablet | Has VMP | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (Bristol-Myers Squibb Pharmaceuticals Ltd) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier | |
| Onglyza 5mg tablets (Waymade Healthcare Plc) | Is a | False | Product containing precisely saxagliptin 5 milligram/1 each conventional release oral tablet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets